{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:23:26Z","timestamp":1777652606053,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T00:00:00Z","timestamp":1442275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lily and Ernst Hausmann Research Trust"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI079497"],"award-info":[{"award-number":["R01AI079497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ebiom.2015.09.025","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T13:18:57Z","timestamp":1442409537000},"page":"1640-1649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis"],"prefix":"10.1016","volume":"2","author":[{"given":"Justin","family":"Shenje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ifeoma Adimora-Nweke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mpiko","family":"Ntsekhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Deffur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jotam","family":"Pasipanodya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawanda","family":"Gumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongani M.","family":"Mayosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2015.09.025_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","article-title":"Pharmacokinetics\u2013pharmacodynamics of antimicrobial therapy: it's not just for mice anymore","volume":"44","author":"Ambrose","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2005.01.066","article-title":"The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions","volume":"118","author":"Ben-Horin","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/pgmj.2003.013664","article-title":"Diagnosis of tuberculous etiology in pericardial effusions","volume":"80","author":"Cherian","year":"2004","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/AAC.03931-14","article-title":"Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis","volume":"59","author":"Chigutsa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0025","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.43.6.1329","article-title":"Intrapulmonary concentrations of pyrazinamide","volume":"43","author":"Conte","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0035","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","article-title":"Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy","author":"Gumbo","year":"2011"},{"key":"10.1016\/j.ebiom.2015.09.025_bb0040","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin","volume":"51","author":"Gumbo","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0045","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1128\/AAC.00185-07","article-title":"Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations","volume":"51","author":"Gumbo","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0050","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/AAC.01681-08","article-title":"Pharmacokinetics\u2013pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs","volume":"53","author":"Gumbo","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0055","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/jac\/dku136","article-title":"The pyrazinamide susceptibility breakpoint above which combination therapy fails","volume":"69","author":"Gumbo","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0060","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1128\/AAC.03549-14","article-title":"Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy","volume":"58","author":"Gumbo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 3","key":"10.1016\/j.ebiom.2015.09.025_bb0065","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiu610","article-title":"Pharmacokinetic\u2013pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia","volume":"211","author":"Gumbo","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2015.09.025_bb0070","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/cid\/civ426","article-title":"Correlations between the hollow fiber model of tuberculosis and therapeutic events in tuberculosis patients: learn and confirm","volume":"61","author":"Gumbo","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2015.09.025_bb0075","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/civ427","article-title":"Forecasting accuracy of the hollow fiber model of tuberculosis for clinical therapeutic outcomes","volume":"61","author":"Gumbo","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0080","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1128\/AAC.05623-11","article-title":"Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.11613\/BM.2014.014","article-title":"Pleural, peritoneal and pericardial effusions \u2014 a biochemical approach","volume":"24","author":"Kopcinovic","year":"2014","journal-title":"Biochem. Med. (Zagreb)"},{"key":"10.1016\/j.ebiom.2015.09.025_bb0090","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1161\/CIRCULATIONAHA.105.543066","article-title":"Tuberculous pericarditis","volume":"112","author":"Mayosi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2015.09.025_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-6-2","article-title":"Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry","volume":"6","author":"Mayosi","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0100","first-page":"36","article-title":"Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa","volume":"98","author":"Mayosi","year":"2008","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1407380","article-title":"Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis","volume":"371","author":"Mayosi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0110","first-page":"748","article-title":"Activation of pyrazinamide and nicotinamide in acidic environments in vitro","volume":"70","author":"McDermott","year":"1954","journal-title":"Am. Rev. Tuberc"},{"key":"10.1016\/j.ebiom.2015.09.025_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1741-7015-12-101","article-title":"Diagnostic accuracy of quantitative PCR (Xpert MTB\/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-gamma in a high burden setting: a prospective study","volume":"12","author":"Pandie","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00749-10","article-title":"An oracle: antituberculosis pharmacokinetics\u2013pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future","volume":"55","author":"Pasipanodya","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/cis353","article-title":"Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy","volume":"55","author":"Pasipanodya","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0130","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/infdis\/jit352","article-title":"Serum drug concentrations predictive of pulmonary tuberculosis outcomes","volume":"208","author":"Pasipanodya","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0135","unstructured":"Pasipanodya JG, Mubanga M, Ntsekhe N, Pandie P, Beki T, Magazi BT, Gumedze F, Myer L, Gumbo T, Mayosi BM. Tuberculous pericarditis is multibacillary and bacterial burden drives high mortality. EBiomed."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/qjmed\/hcl123","article-title":"Diagnosing tuberculous pericarditis","volume":"99","author":"Reuter","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.ebiom.2015.09.025_bb0145","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1086\/651377","article-title":"Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol","volume":"201","author":"Srivastava","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0150","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/infdis\/jir658","article-title":"Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability","volume":"204","author":"Srivastava","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0155","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/AAC.00269-11","article-title":"Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling","volume":"55","author":"Srivastava","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0160","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/AAC.03485-14","article-title":"Exposure to total and protein-unbound rifampin is not affected by malnutrition in indonesian tuberculosis patients","volume":"59","author":"Te Brake","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0009-9120(95)02024-1","article-title":"In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and alpha-1-acid glycoprotein","volume":"29","author":"Woo","year":"1996","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0170","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/AAC.01433-10","article-title":"Protein binding: do we ever learn?","volume":"55","author":"Zeitlinger","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0175","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.ebiom.2015.09.025_bb0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1099\/0022-1317-51-1-42","article-title":"Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide","volume":"51","author":"Zhang","year":"2002","journal-title":"J. Med. Microbiol."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415301420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415301420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T13:07:42Z","timestamp":1567170462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396415301420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2352396415301420"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.09.025","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}